1. Home
  2. ICG vs NMRA Comparison

ICG vs NMRA Comparison

Compare ICG & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICG
  • NMRA
  • Stock Information
  • Founded
  • ICG 2017
  • NMRA 2019
  • Country
  • ICG China
  • NMRA United States
  • Employees
  • ICG N/A
  • NMRA N/A
  • Industry
  • ICG Semiconductors
  • NMRA
  • Sector
  • ICG Technology
  • NMRA
  • Exchange
  • ICG Nasdaq
  • NMRA Nasdaq
  • Market Cap
  • ICG 105.7M
  • NMRA 121.0M
  • IPO Year
  • ICG 2023
  • NMRA 2023
  • Fundamental
  • Price
  • ICG $2.80
  • NMRA $1.26
  • Analyst Decision
  • ICG Strong Buy
  • NMRA Buy
  • Analyst Count
  • ICG 2
  • NMRA 8
  • Target Price
  • ICG $9.25
  • NMRA $9.29
  • AVG Volume (30 Days)
  • ICG 351.4K
  • NMRA 1.6M
  • Earning Date
  • ICG 08-14-2025
  • NMRA 08-05-2025
  • Dividend Yield
  • ICG N/A
  • NMRA N/A
  • EPS Growth
  • ICG N/A
  • NMRA N/A
  • EPS
  • ICG 0.07
  • NMRA N/A
  • Revenue
  • ICG $53,729,346.00
  • NMRA N/A
  • Revenue This Year
  • ICG N/A
  • NMRA N/A
  • Revenue Next Year
  • ICG $141.94
  • NMRA N/A
  • P/E Ratio
  • ICG $38.55
  • NMRA N/A
  • Revenue Growth
  • ICG 384.54
  • NMRA N/A
  • 52 Week Low
  • ICG $1.19
  • NMRA $0.61
  • 52 Week High
  • ICG $12.04
  • NMRA $17.19
  • Technical
  • Relative Strength Index (RSI)
  • ICG 66.82
  • NMRA 69.27
  • Support Level
  • ICG $1.75
  • NMRA $0.72
  • Resistance Level
  • ICG $2.79
  • NMRA $1.18
  • Average True Range (ATR)
  • ICG 0.38
  • NMRA 0.10
  • MACD
  • ICG 0.13
  • NMRA 0.03
  • Stochastic Oscillator
  • ICG 89.18
  • NMRA 74.14

About ICG Intchains Group Limited

Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Share on Social Networks: